If you've missed two or more consecutive doses , the UK product information provides two options: You may resume at your current dose, or Your clinician may consider reinitiating the dose-escalation schedule to reduce gastrointestinal side effects If restarting with the dose-escalation schedule, this typically follows: Weeks 14 : 0.25 mg once weekly Weeks 58 : 0.5 mg once weekly Weeks 912 : 1 mg once weekly Weeks 1316 : 1.7 mg once weekly Week 17 onwards : 2.4 mg once weekly (maintenance dose) If you don't tolerate a dose increase, your clinician may delay it by 4 weeks
To get the most out of weight loss medications, it's important to pair them with well-structured eating plans
The consensus statement recommends GLP-1/GIP therapy for: Adults with T1D who have overweight or obesity (BMI of 30 or higher, or 27 or higher with other health conditions) Adults with T1D who arent hitting their blood sugar goals with insulin alone, even at a healthy weight Teens and young adults with T1D who have overweight or obesity and arent reaching their targets on insulin or who are meeting targets but might still benefit If your BMI drops below 25, or was 25 or under when treatment started, your healthcare provider should check in regularly and may pause or stop the medication altogether
Ergothioneine prevents, abrogates, or inhibits mechanisms implicated in neurodegeneration, thereby conferring neuroprotective effects via neuronal transporters
Get Started With TrimRx 6